Ozi ngwaahịa
Aha:Antitumor Paclitaxel Apis
Nọmba CAS:33069-62-4
Nkọwapụta:99%-102%
Ụdị:API
Ọrụ nke akụrụngwa akụrụngwa paclitaxel
Ngwa ngwa nke paclitaxel nwere mmetụta anticancer dị iche iche ma nwee ike igbochi uto na mgbasa nke mkpụrụ ndụ tumo site na usoro dị iche iche. Ọrụ kachasị mkpa bụ igbochi mitosis nke mkpụrụ ndụ tumo site na igbochi nchịkọta microtubule na usoro decomposition, si otú ahụ na-ebute apoptosis cell tumor ma ọ bụ ọnwụ. Tụkwasị na nke ahụ, paclitaxel nwekwara ike igbochi tumor angiogenesis, belata ihe oriri nke etuto ahụ, na-amụba mmetụta nke mkpụrụ ndụ tumo na ọgwụgwọ radieshon.
Ka ọ dị ugbu a, a na-eji paclitaxel eme ihe n'ọtụtụ ebe n'ịgwọ ọrịa etuto dị iche iche, dị ka ọrịa cancer ovarian, ọrịa ara ara, ọrịa cancer akpa ume, ọrịa afọ afọ, wdg. Enwere ike iji ya naanị ya ma ọ bụ jikọtara ya na ọgwụ mgbochi ọrịa cancer ndị ọzọ iji melite irè ọgwụgwọ. N'otu oge ahụ, a pụkwara iji paclitaxel API mepụta ọgwụ mgbochi ọrịa cancer ọhụrụ, dị ka ndị na-ebu nanoparticle, paclitaxel gbanwere, wdg.
Bụrụ onye na-eweta akụrụngwa na ụlọ ọrụ na-eguzosi ike n'ezi ihe!
Nnọọ ịkpọtụrụ m site na izipu email namarketing@handebio.com